Louis J. Grasmick, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 141,924 shares at $3.52 ($500K) on 2015-01-21, disclosed to the SEC on 2015-01-22.
Open-market purchase of $500k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |